Eli Lilly Acquires Orna Therapeutics in $2.4 Billion Deal to Expand RNA Capabilities | MarketWire

Eli Lilly announces a $2.4 billion deal to acquire Orna Therapeutics, bolstering its RNA drug portfolio.

Read full article on MarketWire